063160.KO Ckd Bio

Healthcare Pharmaceuticals Korea Stock Exchange
11,690 KRW
Close of Nov 5, 2026
10,910 24,900
Market cap
KRW 64.1B
P/E
-
P/B
0.52x
ROE
-12.4%
Dividend yield
0.86%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 063160.KO undervalued?

Graham number

The Graham number of Ckd Bio cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ckd Bio fundamental analysis

No fundamental analysis for Ckd Bio yet.

Ckd Bio stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ckd Bio

CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seo…

Full company profile